Permeation enhancers

Details Permeation enhancers Permeation enhancers

2002-05-13

2010-10-26

Jiang, Shaojia Anna (Department: 1623)

Drug, bio-affecting and body treating compositions

Designated organic nonactive ingredient containing other...

Carboxylic acid or salt thereof

C514S772000, C514S056000

Reexamination Certificate

active

07820722

ABSTRACT:
A pharmaceutical composition comprising a drug and a permeation enhancer that comprises a multi-carbon backbone having a functional group and also one or more side chains which have one or more carbon atoms and, optionally, one or more functional groups.

REFERENCES:
patent: 4525339 (1985-06-01), Behl et al.
patent: 4656161 (1987-04-01), Herr
patent: 4789547 (1988-12-01), Song et al.
patent: 5190748 (1993-03-01), Bachynsky et al.
patent: 5229130 (1993-07-01), Sharma et al.
patent: 5288497 (1994-02-01), Stanley et al.
patent: 5541155 (1996-07-01), Leone-Bay et al.
patent: 5650386 (1997-07-01), Leone-Bay et al.
patent: 5714477 (1998-02-01), Einarsson
patent: 5854281 (1998-12-01), Uekama et al.
patent: 5863555 (1999-01-01), Heiber et al.
patent: 5912009 (1999-06-01), Venkateshwaran et al.
patent: 5952000 (1999-09-01), Venkateshwaran et al.
patent: 5977175 (1999-11-01), Lin
patent: 6001390 (1999-12-01), Yum et al.
patent: 6200602 (2001-03-01), Watts et al.
patent: 6262161 (2001-07-01), Betso et al.
patent: 6264981 (2001-07-01), Zhang et al.
patent: 6326360 (2001-12-01), Kanazawa et al.
patent: 6379960 (2002-04-01), Popoff et al.
patent: 0376 534 (1990-07-01), None
patent: 0 497 162 (1992-08-01), None
patent: 0 517211 (1992-12-01), None
patent: 0 580 074 (1994-01-01), None
patent: 953 626 (1964-03-01), None
patent: 51031687 (1976-03-01), None
patent: 59 073 600 (1984-04-01), None
patent: 2-207018 (1990-08-01), None
patent: 2-282327 (1990-11-01), None
patent: 03 275 633 (1991-12-01), None
patent: 6-40949 (1994-02-01), None
patent: 11-35458 (1999-02-01), None
patent: 2004-4529953 (2004-09-01), None
patent: 2 068 689 (1996-11-01), None
patent: WO 8404674 (1984-12-01), None
patent: WO 9321907 (1993-11-01), None
patent: WO 9522319 (1995-08-01), None
patent: WO 9534294 (1995-12-01), None
patent: WO 9705903 (1997-02-01), None
patent: WO 99/02120 (1999-01-01), None
patent: WO 99/02485 (1999-01-01), None
patent: WO 9902120 (1999-01-01), None
patent: WO 99/45934 (1999-09-01), None
patent: WO 00/22909 (2000-04-01), None
patent: WO 0022909 (2000-04-01), None
patent: WO 00/50012 (2000-08-01), None
patent: WO 02/092070 (2002-11-01), None
Pharmaceutical Research, 1997, 14(2), 1772-1779.
Critical Reviews in Therapeutic Drug Carrier Systems, 1990, 7(1), 1-133.
Critical Reviews in Therapeutic Drug Carrier Systems, 1991, 8(2), 91-192.
Brayden et al , Pharmaceutical Research, 1997, 14(12), 1772-1779.
Muranishi, Critical Reviews in Therapeutic Drug Carrier Systems, 1990, 7(1), 1-133.
Lee et al, Critical Reviews in Therapeutic Drug Carrier Systems, 1991, 8(2), 91-192.
Brayden et al, Pharmaceutical Research, 1997, 14(12), 1772-1779.
Aungst, B.J. et al., Enhancement of the Intestinal Absorption of Peptides and Non-peptides, J. of Controlled Release (1996), 41:19-31.
Lindmark, T. et al., Mechanism of Aborption Enhancement in Humans After Rectal Adminstration of Ampicillin in Suppositories Containing Sodium Caprate, Pharmaceutical Research (1997), 14: 930-935.
Anderberg, E.K. et al., Sodium Caprate Elicits Dilatations in Human Intestinal Tight Junctions and Enhances Drug Absorption by the Paracellular Route, Pharmaceutical Research (1993), 10: 857-864.
Yeh, P. et al., Effect of Medium-chain Glycerides on Physiological Properties of Rabbit Intestinal Epithelium in Vitro, Pharmaceutical Research (1994), 11: 1148-1154.
Artursson, P., Epithelial Transport of Drugs in Cell Culture. I: A Model for Studying the Passive Diffusion of Drugs over Intestinal Absorbative (Caco-2) Cells, J. Pharmaceutical Studies (1990), 79: 476-482.
Doluisio, J.T. et al., Drug Absorption I: An In Situ Rat Gut Technique Yielding Realistic Asorption Rates, J. Pharmaceutical Studies (1969), 59: 1196-1200.
Brayden, D. et al., Heparin Absorption Across the Intestine: Effects of Sodium N-[8-(2-Hydroxybenzoyl)Amino]Caprylate in Rat In Situ Intestinal Instillations and in Caco-2 Monolayers, Pharmaceutical Research (1997), 14: 1772-1779.
Cumming, K.I. and A.J. Winfield, In Vitro Evaluation of a Series of Sodium Carboxylates as Dermal Penetration Enhancers, Int. J. Pharm. (1994), 108: 141-148.
Tomita, M. et al., Enhancement of Colonic Drug Absorption by the Paracellular Permeation Route, Pharmaceutical Research (1988), 5: 341-346.
Gennaro, A. R., Remington: The Science and Practice of Pharmacy (1995), 1618.
Oda et al., Proc. Int'l Symp. Control. Rel. Bioact. Mater. 24 (1997) 283-284.
Bennett, D. et al., Pulmonary Delivery of Detirelix Intratracheal Instillation and Aerosol Inhalation in the Briefly Anesthetized Dog, Pharmaceutical Research (1994), vol. 11, No. 7, 1048-1054.
Cumming et al. “In vitro evaluation of a series of sodium carboxylates as dermal penetration enhancers”,International J. of Pharmaceutics108:141-148 (1994).
Supplementary European Search Report corresponding to European Application No. 02731786.6 mailed Jun. 6, 2008.
Aungst. “Structure/Effect Studies of Fatty Acid Isomers as Skin Penetration Enhancers and Skin Irritants”Pharmaceutical Research6(3):244-247 (1989).
Notice of Reasons for Rejections and English translation for Japanese Patent Application No. 2002-588986, mailed Feb. 3, 2009 (6 pages).
Schneider et al. “Evaluation of Drug Penetration into Human Skin Ex Vivo Using Branched Fatty Acids and Propylene Glycol”International Journal of Pharmaceutics145:187-196 (1996).
International Journal of Pharmaceutics, 1994, vol. 108(2), pp. 141-148 In Vitro Evaluation of a Series of Sodium Carboxylates as Dermal Penetration Enhancers, K.I. Cumming and A.J. Winfield.

Affiliated with

Also associated with

Rating

Permeation enhancers does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Permeation enhancers, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Permeation enhancers will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4167590